Sponsor Pipeline

SineuGene Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07169175 A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS Amyotrophic Lateral Sclerosis (ALS) Not Yet Recruiting
Disease Areas
ALS (1)
Get alerts when SineuGene Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free